A Guide to Estimating Conditional Average Treatment Effects in Competing Risks Settings

• URL: http://arxiv.org/abs/2606.18281v1
• Date: Mon, 08 Jun 2026 15:58:08 GMT
• Title: A Guide to Estimating Conditional Average Treatment Effects in Competing Risks Settings
• Abstract summary: Conditional average treatment effects (CATEs) are central to treatment decision-making in personalized medicine.<n>In competing risks settings, estimating CATEs from survival data allows for patient-specific assessments of treatment effectiveness.<n>We study meta-learners which adapt machine learning algorithms for CATE estimation in competing risks scenarios.
• Score: 1.7900262205172117
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Conditional average treatment effects (CATEs) are central to treatment decision-making in personalized medicine. In competing risks settings, estimating CATEs from survival data allows for patient-specific assessments of treatment effectiveness for a specific event of interest while properly accounting for alternative event types. This distinction is essential in the presence of comorbidities, where competing causes of death may otherwise confound the therapeutic benefit. Focusing on right-censored survival times with binary treatment, we examine CATEs defined as covariate-conditional differences in the absolute risk for the event of interest at a fixed time. To this end, we study meta-learners which adapt machine learning algorithms for CATE estimation in competing risks scenarios. We systematically compare six meta-learners, combining Cox regression or random survival forests for risk modeling with elastic net regression or random forests for direct CATE modeling. To provide practical guidance on model selection, we evaluate their performance in multiple simulation settings, that differ in hazard complexity, treatment heterogeneity, treatment assignment, event type distribution and censoring. To facilitate applied use, we provide the R package, crsurvlearners, which implements all considered approaches.

Related papers

• Surv-IPTB: An Attention-Based Model for Estimating Individual Probability of Treatment Benefit with Survival Data [0.6882042556551609]
  The proposed model, called Surv-IPTB, directly quantifies the probability that a specific patient will experience extended survival time under treatment versus control.<n>We reformulate IPTB estimation as a binary classification problem, leveraging pairwise patient comparisons across treatment and control cohorts.<n>An attention mechanism with learnable query-key transformations enables flexible, data-driven aggregation of pairwise comparisons.
  arXiv  Detail & Related papers  (2026-08-06T17:13:44Z)
• Orthogonal machine learning for conditional odds and risk ratios [0.0]
  We review existing methods and propose novel ones, focusing on the odds ratio (OR) and the risk ratio (RR)<n>We derive orthogonal risk functions for the OR and RR and show that the associated pseudo-outcomes satisfy second-order conditional-mean remainder properties analogous to the ATE case.<n>We also evaluate estimators for the conditional ATE, OR, and RR in a comprehensive nonparametric Monte Carlo simulation study to compare them with common alternatives under hundreds of different data-generating distributions.
  arXiv  Detail & Related papers  (2026-04-12T02:14:58Z)
• Assessing the robustness of heterogeneous treatment effects in survival analysis under informative censoring [50.164756034797136]
  Dropout is common in clinical studies, with up to half of patients leaving early due to side effects or other reasons.<n>When dropout is informative, it introduces censoring bias, because of which treatment effect estimates are also biased.<n>We propose an assumption-lean framework to assess the robustness of conditional average treatment effect estimates in survival analysis when facing censoring bias.
  arXiv  Detail & Related papers  (2025-10-15T10:51:17Z)
• Comparison of the Cox proportional hazards model and Random Survival Forest algorithm for predicting patient-specific survival probabilities in clinical trial data [0.0]
  Cox proportional hazards model is often used to analyze data from Randomized Controlled Trials (RCT) with time-to-event outcomes.<n> Random survival forest (RSF) is a machine-learning algorithm known for its high predictive performance.<n>We compare the performance of Cox regression and RSF in various simulation scenarios based on two reference from RCTs.
  arXiv  Detail & Related papers  (2025-02-05T12:26:43Z)
• Meta-Learners for Partially-Identified Treatment Effects Across Multiple Environments [67.80453452949303]
  Estimating the conditional average treatment effect (CATE) from observational data is relevant for many applications such as personalized medicine. Here, we focus on the widespread setting where the observational data come from multiple environments. We propose different model-agnostic learners (so-called meta-learners) to estimate the bounds that can be used in combination with arbitrary machine learning models.
  arXiv  Detail & Related papers  (2024-06-04T16:31:43Z)
• Continuous-Time Modeling of Counterfactual Outcomes Using Neural Controlled Differential Equations [84.42837346400151]
  Estimating counterfactual outcomes over time has the potential to unlock personalized healthcare. Existing causal inference approaches consider regular, discrete-time intervals between observations and treatment decisions. We propose a controllable simulation environment based on a model of tumor growth for a range of scenarios.
  arXiv  Detail & Related papers  (2022-06-16T17:15:15Z)
• Robust and Agnostic Learning of Conditional Distributional Treatment Effects [44.31792000298105]
  We provide a new robust and model-agnostic methodology for learning the conditional DTE (CDTE) for a class of problems.<n>Our method is model-agnostic in that it can provide the best projection of CDTE onto the regression model class.<n>We investigate the behavior of our proposal in simulations, as well as in a case study of 401(k) eligibility effects on wealth.
  arXiv  Detail & Related papers  (2022-05-23T17:40:31Z)
• Treatment Effect Risk: Bounds and Inference [58.442274475425144]
  Since the average treatment effect measures the change in social welfare, even if positive, there is a risk of negative effect on, say, some 10% of the population. In this paper we consider how to nonetheless assess this important risk measure, formalized as the conditional value at risk (CVaR) of the ITE distribution. Some bounds can also be interpreted as summarizing a complex CATE function into a single metric and are of interest independently of being a bound.
  arXiv  Detail & Related papers  (2022-01-15T17:21:26Z)
• SurvITE: Learning Heterogeneous Treatment Effects from Time-to-Event Data [83.50281440043241]
  We study the problem of inferring heterogeneous treatment effects from time-to-event data. We propose a novel deep learning method for treatment-specific hazard estimation based on balancing representations.
  arXiv  Detail & Related papers  (2021-10-26T20:13:17Z)
• WRSE -- a non-parametric weighted-resolution ensemble for predicting individual survival distributions in the ICU [0.251657752676152]
  Dynamic assessment of mortality risk in the intensive care unit (ICU) can be used to stratify patients, inform about treatment effectiveness or serve as part of an early-warning system. We show competitive results with state-of-the-art probabilistic models, while greatly reducing training time by factors of 2-9x.
  arXiv  Detail & Related papers  (2020-11-02T10:13:59Z)
• Enabling Counterfactual Survival Analysis with Balanced Representations [64.17342727357618]
  Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
  arXiv  Detail & Related papers  (2020-06-14T01:15:00Z)
• Survival Analysis Using a 5-Step Stratified Testing and Amalgamation Routine in Randomized Clinical Trials [0.0]
  Increased patient heterogeneity can weaken the ability of common statistical approaches to detect treatment differences. A list of baseline covariates that have the potential to be prognostic for survival under either treatment is pre-specified. A conditional inference tree algorithm is used to segment the heterogeneous trial population into subpopulations of prognostically homogeneous patients. The impressive power-boosting performance of our proposed 5-step stratified testing and amalgamation routine (5-STAR) is illustrated.
  arXiv  Detail & Related papers  (2020-04-28T15:44:41Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.